72.11.Z - Scientific research and development activities
20.12.Z - Manufacture of dyes and pigments
21.10.Z - Manufacture of basic pharmaceutical products
2018 | 2019 | 2020 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Assets | 82,7 | 82,7 | 82,7 | 0 |
Gross profit (loss) | -6,3 | 0 | 0 | 0 |
EBITDA | -6,3 | 0 | 0 | 0 |
Net profit (loss) | -6,3 | 0 | 0 | 0 |
Cash | 42,7 | 42,7 | 42,7 | 0 |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 0 | 0 | 0 | 0 |
Short time liabilities | 0 | 0 | 0 | 0 |
Equity capital | 82,7 | 82,7 | 82,7 | 0 |
Working assets | 79 | 79 | 79 | 0 |
Operating profit (EBIT) | -6,3 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -7,6 | 0 | 0 | 0 |
Equity capital to total assets | 100 | 100 | 100 | 0 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 0 | 0 | 0 | 0 |
Net dept to EBITDA | 6.769557476043701 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane